These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17909302)

  • 1. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
    Driver-Dunckley ED; Noble BN; Hentz JG; Evidente VG; Caviness JN; Parish J; Krahn L; Adler CH
    Clin Neuropharmacol; 2007; 30(5):249-55. PubMed ID: 17909302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
    Quickfall J; Suchowersky O
    Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.
    Tippmann-Peikert M; Park JG; Boeve BF; Shepard JW; Silber MH
    Neurology; 2007 Jan; 68(4):301-3. PubMed ID: 17242339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist: pathological gambling and hypersexuality.
    Prescrire Int; 2008 Oct; 17(97):200-1. PubMed ID: 19536937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 9. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
    Bayard S; Langenier MC; Dauvilliers Y
    Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
    Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
    Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
    Molokwu OC
    Ann Pharmacother; 2008 May; 42(5):627-32. PubMed ID: 18381842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
    Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
    Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.